- 专利标题: CLINICAL CORRELATES OF IMMUNOTHERAPY EFFICACY
-
申请号: US15594167申请日: 2017-05-12
-
公开(公告)号: US20170312355A1公开(公告)日: 2017-11-02
- 发明人: John CONNOLLY , Richard HOPKINS , Han Chong TOH
- 申请人: AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH , TESSA THERAPEUTICS PTE. LTD. , SINGAPORE HEALTH SERVICES PTE. LTD.
- 优先权: SG10201509979S 20151204
- 主分类号: A61K39/245
- IPC分类号: A61K39/245 ; C12Q1/70 ; G01N33/574 ; C12N7/00 ; A61K39/00
摘要:
A method for predicting whether a patient will be a long-term survivor on treatment of a disease by adoptive cell transfer (ACT), is disclosed comprising: (i) analysing a blood-derived sample obtained from the patient for one or more prognostic markers of long-term survival on treatment of a disease by ACT, and; (ii) based on the analysis of step (i), predicting whether the patient will be a long-term survivor on treatment of the disease by ACT. Also disclosed are methods for treating a patient by ACT, methods for selecting a patient for treatment by ACT, and methods for selecting a patient for treatment of a disease by ACT.
公开/授权文献
信息查询